Age, the presence of HLH, the pathological type (cutaneous), the plasma EBV load (1 × 104 copies/ml), the presence of a panel mutation, the tendency for tumor transformation, the presence of dynamic changes in Ki-67 expression and pathology are prognostic risk factors. Here, MKI67 is linked to hemophagocytic syndrome.